FT Options’s Radius Health, Inc. RDUS Stock Holding History

FT Options’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-28,116	Closed	-$1.07M	–	379
2016 Q4	$1.07M	Buy	28,116 +2,363	+9%	+$112K	1.23%	19
2016 Q3	$1.39M	Buy	+25,753	New	+$1.31M	1.1%	22

Other funds holding RDUS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

FT Options's RDUS Position: Q1 2017 in Review

FT Options sold out of Radius Health, Inc. (RDUS) in Q1 2017, closing a stake of 28,116 shares — an estimated $1.07M sold.

FT Options first reported a position in RDUS in Q3 2016 and held it in 2 quarters. The position peaked at $1.39M in Q3 2016. 152 funds tracked by Wall St. Rank hold RDUS as of Q1 2017.

FT Options reported no remaining Radius Health, Inc. position as of Q1 2017 after selling out during the quarter.
FT Options sold 28,116 Radius Health, Inc. shares in Q1 2017, an estimated $1.07M.
FT Options first reported a position in Radius Health, Inc. in Q3 2016 and held it in 2 quarters.
FT Options's Radius Health, Inc. position peaked at $1.39M in Q3 2016.
152 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2017.

Based on FT Options's 13F filing for Q1 2017, filed 12 May 2017.